Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:58 AM
Ignite Modification Date:
2025-12-25 @ 12:58 AM
NCT ID:
NCT06273293
Eligibility Criteria:
Inclusion Criteria:
* Patients \>18 years old and,
* Patients with multivessel coronary artery disease (multivessel coronary artery disease will be considered the presence of significant stenosis in 2 or more first or second order vessels greater than 1.5 mm in diameter with an angiographic reduction of their diameter ≥50% by visual estimation) subsidiary of percutaneous coronary revascularization in at least one of them and,
* Use of Navvus pressure microcatheter both for functional diagnosis and for post-PCI evaluation of the different vessels and,
* Patients who have signed the Informed Consent.
Exclusion Criteria:
* Patients with intolerance or contraindication to adenosine.
* Hemodynamically unstable patients, acute phase of a STEACS.
* Patient with significant comorbidity with limited life expectancy.
* Patients with the patient's express refusal to participate in the study.
* Pregnant or breastfeeding female patients.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06273293
Study Brief:
Protocol Section:
NCT06273293